The report presents an in-depth assessment of the Human Chorionic Gonadotropin (HCG) Market including latest developments, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Human Chorionic Gonadotropin (HCG) Market investments from 2019 till 2025.
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
In 2019, the market size of Human Chorionic Gonadotropin (HCG) is 390 million US$ and it will reach 620 million US$ in 2025, growing at a CAGR of 6.0% from 2019
Top Manufacturers profiled in the report are:
EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, LLC, Scrippslabs, Leebio, Kamiya Biomedical Company, Sanzyme, Cigna
Free Sample/Inquiry at:
Below is the Short Brief of the Global Human Chorionic Gonadotropin (HCG) Market Report:
Human Chorionic Gonadotropin (HCG) Market, by Types:
Natural Source Extraction
Recombinant DNA Technology
Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
Female Infertility Treatment
(Special Offer: Get flat 15% discount on this report)
Browse Full Report at:
Human Chorionic Gonadotropin (HCG) Market segment by Regions/Countries, this report covers:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.),
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
Global Human Chorionic Gonadotropin (HCG) Market research provides answers to the following key questions:
-What will be the market size and the growth rate in 2025?
-What are the key factors driving the market?
-Who are the key market players and what are their strategies in the market?
-What are the key market trends impacting the growth of the market?
-What trends, challenges and barriers are influencing its growth?
-What are the market opportunities and threats faced by the vendors in the market?
-What are the key outcomes of the five forces analysis of Human Chorionic Gonadotropin (HCG) market?
The study objectives are:
To analyze and research the Human Chorionic Gonadotropin (HCG) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Chorionic Gonadotropin (HCG) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Reach us: Irfan Tamboli (Head of Sales)
Emails: email@example.com / firstname.lastname@example.org
Phone: + 1704 266 3234 / +91-750-707-8687